Skip to content
Screener

Bioventus BVS Finance Lease Liabilities

Finance Lease Liabilities at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$12.9M-26.0%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$3K-92.3%
Medtronic logo
MedtronicMDT
$54M+3.8%
Globus Medical logo
Globus MedicalGMED
$380K+120%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$10.82M+10,941%
Artivion logo
ArtivionAORT
$2.8M-8.3%

Other financials

Income statement

See full
Revenue$153.2M+3.8%
Gross profit$105.7M+3.5%
Operating income$19.1M+4.1%
Net income$33.4M+348%
EPS (diluted)$0.47+327%

Balance sheet

See full
Cash & equivalents$29.5M-10.5%
Total debt$263.7M-26.9%
Total equity$228.3M+41.6%
Total assets$673.3M-4.7%

Cash flow

See full
Operating cash flow$19.9M-23.4%
CapEx$960.0K+40.6%
Free cash flow$18.9M-25.1%

Valuation

See full
Market cap$1.19B+156%
Enterprise value$1.42B+79.7%
P/E21.8×
P/S+1.2×

Profitability

See full
Gross margin68.7%+1.1pp
Operating margin10%
Net margin9.4%+9.2pp
FCF margin16.2%+10.2pp

Returns & leverage

See full
Return on equity28%+27.5pp
Debt / equity1.2×-1.1×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.

The source filing: Bioventus’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:43 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001665988-26-000042
Line itemJune 27, 2026December 31, 2025
Total operating lease liabilities$6,109$7,759
Property, plant and equipment, net$10,451$11,221
Finance lease liabilities—other current liabilities$960$907
Finance lease liabilities—other long-term liabilities8,2288,729
Total financing lease liabilities$9,188$9,636
Weighted-average remaining lease term (years):
Operating leases2.02.4
Finance leases6.87.3

Item 1. Financial Statements (Unaudited)

FAQ

What is Bioventus's finance lease liabilities?
Bioventus (BVS) reported finance lease liabilities of $8.23M in Q2 2026.
How has Bioventus's finance lease liabilities changed year-over-year?
Bioventus's finance lease liabilities decreased by 10.4% year-over-year, from $9.19M to $8.23M.
What is the long-term trend for Bioventus's finance lease liabilities?
Over 3 years (2022 to 2025), Bioventus's finance lease liabilities has grown at a 386.1% compound annual growth rate (CAGR), from $76K to $8.73M.
What does finance lease liabilities mean?
Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.

Ask your AI about Bioventus's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude